16:50 EDT NLS Pharmaceutics (NLSP) files to sell 5M common shares for holders
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NLSP:
- NLS Pharmaceutics Engages New Accounting Firm After Marcum’s Resignation
- NLS Pharmaceutics and Kadimastem Secure SEC Approval for Merger
- NLS Pharmaceutics and Kadimastem Secure Hong Kong Patent for Diabetes Therapy
- NLS Pharmaceutics and Kadimastem granted patent in Hong Kong for diabetes
- NLS Pharmaceutics Extends Merger Agreement with Kadimastem